These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

69 related items for PubMed ID: 120168

  • 1. Animal models for an integrated approach to the pharmacologic control of atherosclerosis.
    Day CE, Phillips WA, Schurr PE.
    Artery; 1979 Feb; 5(2):90-109. PubMed ID: 120168
    [Abstract] [Full Text] [Related]

  • 2. Utility of selected line (SEA) of the Japanese quail (Coturnix coturnix japonica) for the discovery of new anti-atherosclerosis drugs.
    Day CE, Stafford WW, Schurr PE.
    Lab Anim Sci; 1977 Oct; 27(5 Pt 2):817-21. PubMed ID: 592732
    [Abstract] [Full Text] [Related]

  • 3. [Experimental hypolipidemic and antiatherosclerotic activity of bisanions].
    Ryzhenkov VE, Khromov-Borisov NV, Mosina IV, Indenbom ML.
    Farmakol Toksikol; 1979 Oct; 42(6):632-5. PubMed ID: 499472
    [Abstract] [Full Text] [Related]

  • 4. Selected animal models for systematic antiatherosclerotic drug development.
    Day CE, Schurr PE, Phillips WA.
    Adv Exp Med Biol; 1978 Oct; 109():277-83. PubMed ID: 215005
    [Abstract] [Full Text] [Related]

  • 5. Anti-atherosclerotic activity of colestipol hydrochloride in SEA quail.
    Day CE.
    Artery; 1990 Oct; 17(3):119-26. PubMed ID: 2337384
    [Abstract] [Full Text] [Related]

  • 6. Atherosclerosis in Japanese quail and the effect of lipoic acid.
    Shih JC.
    Fed Proc; 1983 May 15; 42(8):2494-7. PubMed ID: 6404656
    [Abstract] [Full Text] [Related]

  • 7. Hypolipemic profile of plafibride in a model of experimental atherosclerosis.
    Badimón JJ, Padró T, Cánovas M, Vidal M, Villaverde CA.
    Methods Find Exp Clin Pharmacol; 1983 Nov 15; 5(9):613-7. PubMed ID: 6668971
    [Abstract] [Full Text] [Related]

  • 8. [Biochemical and experimental aspects of the lipid-lowering drugs pharmacology (author's transl)].
    Jacotot B.
    Sem Hop; 1983 Nov 15; 55(41-42):1947-55. PubMed ID: 231322
    [Abstract] [Full Text] [Related]

  • 9. Combined vessel injuring action of adjuvant arthritis and cholesterol feeding. II. The influence of different types of drugs on the new model of experimental atherosclerosis.
    Virág S, Vértesi C, Welner I.
    Ther Hung; 1976 Nov 15; 24(4):142-4. PubMed ID: 1013930
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Atherosclerosis in rhesus and cynomolgus monkeys.
    Armstrong ML.
    Primates Med; 1976 Nov 15; 9():16-40. PubMed ID: 813206
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Anti-atherosclerotic and plasma lipid lowering effects of the novel calcium blocker with alpha 1-adrenoceptor antagonistic activity, monatepil, in high cholesterol diet-fed Japanese Macaca fuscata monkeys.
    Miyazaki M, Hosoki K, Okunishi H, Ishii K, Ikeno A, Okazaki Y.
    Arzneimittelforschung; 1994 Mar 15; 44(3):288-97. PubMed ID: 8192692
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Atherosclerosis in old world monkeys.
    Clarkson TB, Hamm TE, Bullock BC, Lehner ND.
    Primates Med; 1976 Mar 15; 9():66-89. PubMed ID: 813211
    [No Abstract] [Full Text] [Related]

  • 17. AGI-1067: a multifunctional phenolic antioxidant, lipid modulator, anti-inflammatory and antiatherosclerotic agent.
    Sundell CL, Somers PK, Meng CQ, Hoong LK, Suen KL, Hill RR, Landers LK, Chapman A, Butteiger D, Jones M, Edwards D, Daugherty A, Wasserman MA, Alexander RW, Medford RM, Saxena U.
    J Pharmacol Exp Ther; 2003 Jun 15; 305(3):1116-23. PubMed ID: 12626663
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Social behavior and gender in biomedical investigations using monkeys: studies in atherogenesis.
    Kaplan JR, Adams MR, Clarkson TB, Manuck SB, Shively CA.
    Lab Anim Sci; 1991 Aug 15; 41(4):334-43. PubMed ID: 1658480
    [Abstract] [Full Text] [Related]

  • 20. [The hypolipidemic and antiatherosclerotic action of absorbable and nonabsorbable substances in the intestines].
    Ryzhenkov VE, Chistiakova AM, Okunevich IV.
    Patol Fiziol Eksp Ter; 1989 Aug 15; (5):16-9. PubMed ID: 2616207
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.